Brought to you by 
Emergent acquires overdose and addiction treatment-focused Adapt for up to $735mm
31 Aug 2018
Executive Summary
Emergent BioSolutions Inc. agreed to acquire private specialty pharmaceutical company Adapt Pharma Ltd. (focused on overdose and addiction treatments) for up to $735mm in cash and stock. Emergent expects the transaction will contribute additional revenues of $200-220mm in 2019.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Nasal
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Emergent acquires overdose and addiction treatment-focused Adapt for up to $735mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice